← Eichor
Study identifier: NCT07493629 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Immune Status and Disease Control of Inflammatory Airway Diseases

Condition: Airway Inflammation · Chronic Obstructive Pulmonary Disease (COPD) · Asthma (Diagnosis)  ·  Sponsor: First Affiliated Hospital of Ningbo University

PhaseN/A
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The goal of this study is to learn how the body's immune system affects disease control in people with different airway inflammatory diseases.We want to understand: 1.Whether specific immune cell patterns in the blood are linked to how severe the disease is or how well it is controlled. Participants will: 1. Answer questions about their health and symptoms. 2. Give blood samples 3. Have lung function tests and other standard check-ups. 4. share sleep study results. We will compare people with airway diseases to healthy volunteers to see how their immune systems differ.

This description comes directly from the study's public registry record.

Talk to the study team

chao Cao, Doctor  ·  +86-0574-87085233  ·  caocdoctor@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

The First Affiliated Hospital of Ningbo UniversityNingbo, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07493629